SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-21-031789
Filing Date
2021-12-17
Accepted
2021-12-17 06:09:42
Documents
15

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 50094
2 ex3-1.htm EX-3.1 130750
3 ex3-2.htm EX-3.2 14088
4 ex10-2.htm EX-10.2 11773
5 ex-hcw_001.jpg GRAPHIC 405662
6 ex-hcw_002.jpg GRAPHIC 485611
7 ex-hcw_003.jpg GRAPHIC 549496
8 ex-hcw_004.jpg GRAPHIC 407520
9 ex-hcw_005.jpg GRAPHIC 434768
10 ex-hcw_006.jpg GRAPHIC 445747
11 ex-hcw_007.jpg GRAPHIC 510243
12 ex-hcw_008.jpg GRAPHIC 503367
13 ex-hcw_009.jpg GRAPHIC 82696
14 ex-hcw_010.jpg GRAPHIC 99501
15 ex-hcw_011.jpg GRAPHIC 94603
  Complete submission text file 0001493152-21-031789.txt   5743755
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36199 | Film No.: 211499442
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences